Frutarom Health BU, Switzerland, has introduced EFLApharm, a flagship proprietary product line comprised of both phytopharmaceutical ingredients and pharma flavors. The new product line for the pharmaceutical industry expands the established EFLA brand, offering the company’s expertise in building a supply chain for sustainable, natural Active Pharmaceutical Ingredients that meet pharmaceutical manufacturers’ needs.
 
The EFLApharm family of products are scientifically supported, natural, pharmaceutical-grade herbal extracts. All are produced according to strict GMP guidelines. Examples of herbals used in traditional medicine products under the EFLApharm brand include: Echinacea purpurea L. (purple coneflower), Hedera helix L. (common ivy), and Thymus vulgaris L. (thyme), all of which are key ingredients in the growing field of cough and cold therapeutics.
 
EFLApharm products fall into the Traditional Herbal Medicinal Products (THMP) regulatory framework, and are suitable for global, pharmaceutical-quality submission, including the Drug Master File.
 
“Quality continues to be a major theme across the nutritional and pharmaceutical ingredients marketplace,” explained Hadar Sutovsky, global manager of the Pharma & OTC segment at the Frutarom Health Business Unit. “Companies throughout the supply chain are taking a closer look at the quality of their ingredients and trying to determine better ways to deliver finished products of the highest quality. With EFLApharm, we can simplify access to the market for pharmaceutical companies striving to launch safe and effective herbal medicines.”
 
EFLApharm products also offer GMP-quality fruit flavors with long-lasting taste profiles and masking properties. The ingredients are positioned for oral care products, nutritional supplements, cough syrups and other pharmaceutical dosage forms.
 
For more information:www.frutaromhealth.com